Nanotherapeutics for enhancing thermal therapy of cancer (Q40063990)

17 September 2017

Nanotherapeutics for enhancing thermal therapy of cancer (English)

1 reference

17 September 2017

Emad Ebbini

5

1 reference

ORCID Public Data File 2021

author name string

Rachana Visaria

1

1 reference

17 September 2017

John C Bischof

2

1 reference

17 September 2017

Melissa Loren

3

1 reference

17 September 2017

Brent Williams

4

1 reference

17 September 2017

Giulio Paciotti

6

1 reference

17 September 2017

Robert Griffin

7

1 reference

17 September 2017

1 September 2007

1 reference

International Journal of Hyperthermia

17 September 2017

1 reference

17 September 2017

23

1 reference

17 September 2017

6

1 reference

17 September 2017

501-511

1 reference

Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment

17 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

A phase I study to study arsenic trioxide with radiation and hyperthermia in advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Combretastatin A-4 disodium phosphate: a vascular targeting agent that improves that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Improving local tumor control by combining vascular targeting drugs, mild hyperthermia and radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Vascular targeting agents as cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

TNF-alpha in vivo stimulates apoptosis in fibroblasts through caspase-8 activation and modulates the expression of pro-apoptotic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Improved cryosurgery by use of thermophysical and inflammatory adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Combined treatment of IL-1 alpha and TNF-alpha potentiates the antitumour effect of hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Tumor necrosis factor, cancer and anticancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Current uses of isolated limb perfusion in the clinic and a model system for new strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-alpha delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Pre-treatment inflammation induced by TNF-alpha augments cryosurgical injury on human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

TNF-alpha-based accentuation in cryoinjury--dose, delivery, and response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

The first phase I study of a novel ultrasound contrast agent (BR14): assessment of safety and efficacy in liver and kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Tumour necrosis factor in man: clinical and biological observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Re-setting the biologic rationale for thermal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Biodistribution and tumor localization of stealth liposomal tumor necrosis factor-alpha in soft tissue sarcoma bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Hyperthermia-regulated immunogene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Drug delivery and transport to solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Engineering aspects of hyperthermia therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Direct evidence for rapid and selective induction of tumor neovascular permeability by tumor necrosis factor and a novel derivative, colloidal gold bound tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Tumour necrosis factor-alpha as a tumour promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Tumor necrosis factor or tumor promoting factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701611241

10.1080/02656730701611241

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference